Benzo(a)pyrene-induced changes in p53 and related proteins in mouse skin

Pharmacology and Toxicology

Volumn 92, Issue 5, 2003, Pages 242-245

  Serpi, Raisa ^a   Vähäkangas, Kirsi ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; PROTEIN P53;

ANIMAL TISSUE; ARTICLE; CELL CYCLE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN MODIFICATION;

ANIMALS; BENZO(A)PYRENE; CARCINOGENS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; IMMUNOBLOTTING; MALE; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SKIN; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0037407490     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.920507.x     Document Type: Article

References (23)

1. Alarcon-Vargas, D. & Z. Ronai: p53-Mdm2 - the affair that never ends. Carcinogenesis 2002, 23, 541-547 (review).
2. Bjelogrlic, N. M., M. Mäkinen, F. Stenbäck & K. Vähäkangas: Benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis 1994, 15, 771-774.
3. Epstein, J. H. & J. E. Cleaver: 3-aminobenzamide can act as a cocarcinogen for ultraviolet light-induced carcinogenesis in mouse skin. Cancer Res 1992, 52, 4053-4054.
4. Guimaraes, D. P. & P. Hainaut: TP53: a key gene in human cancer. Biochimie 2002, 84, 83-93 (review).
5. Hainaut, P. & K. Vähäkangas: p53 as a sensor of carcinogenic exposures: mechanisms of p53 protein induction and lessons from p53 gene mutations. Pathol. Biol. (Paris) 1997, 45, 833-844 (review).
6. Kapoor, M. & G. Lozano: Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation. Proc. Natl. Acad. Sci. USA 1998, 95, 2834-2837.
7. Khanna, K. K. & M. F. Lavin: Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 1993, 8, 3307-3312.
8. Lu, K. P., L. M. Hallberg, J. Tomlinson & K. S. Ramos: Benzo(a)-pyrene activates L1Md retrotransposon and inhibits DNA repair in vascular smooth muscle cells. Mutat. Res. 2000, 454, 35-44.
9. Ludwig, A., M. Dietel, G. Schäfer, K. Müller & H. Hilz: Nicotinamide and nicotinamide analogues as antitumor promoters in mouse skin. Cancer Res. 1990, 50, 2470-2475.
10. Menegazzi, M., A. Scarpa, A. Carcereri de Prati, F. Menestrina & H. Suzuki: Correlation of poly(ADP-ribose)polymerase and p53 expression levels in high-grade lymphomas. Mol. Carcinog. 1999, 25, 256-261.
11. Pei, X.-H., Y. Nakanishi, K. Takayama, F. Bai & N. Hara: Benzo(a)pyrene activates the human p53 gene through induction of nuclear factor κB activity. J. Biol. Chem. 1999, 274, 35240-35246.
12. Purnell, M. R. & W. J. D. Whish: Novel inhibitors of poly(ADP-ribose)synthetase. Biochem. J. 1980, 185, 775-777.
13. Rämet, M., K. Castrén, K. Järvinen, K. Pekkala, T. Turpeenniemi-Hujanen, Y. Soini, P. Pääkkö & K. Vähätkangas: p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis 1995, 16, 2117-2124.
14. Serpi, R., J. Piispala, M. Järvilehto & K. Vähäkangas: Thapsigargin has similar effect on p53 protein response to benzo(a)pyrene-DNA adducts as TPA in mouse skin. Carcinogenesis 1999, 20, 1755-1760.
15. Simbulan-Rosenthal, C. M., D. S. Rosenthal, R. B. Luo & M. E. Smulson: Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells. Cancer Res. 1999, 59, 2190-2194.
16. Smith, S.: The world according to PARP. Trends Biochem. Sci. 2001, 26, 174-179.
17. Tapiainen, T., K. Järvinen, R Pääkkö, N. Bjelogrlic & K. Vähäkangas: TPA decreases the p53 response to benzo(a)pyrene-DNA adducts in vivo in mouse skin. Carcinogenesis 1996, 17, 1377-1380.
18. Tong, W.-M., U, Cortes & Z.-Q. Wang: Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis. Biochim. Biophys. Acta 2001, 1552, 27-37.
19. Turpeinen, M., R. Serpi, M. Rahkolin, & K. Vähäkangas: Comparison of anti-p53 antibodies in immunoblotting. Biochem. Biophys. Res. Commun. 2002, 293, 850-856.
20. Venkatachalam, S., M. Denissenko & A. A. Wani: Modulation of (±)-anti-BPDE mediated p53 accumulation by inhibitors of protein kinase C and poly(ADP-ribose) polymerase. Oncogene 1997, 14, 801-809.
21. Vähäkangas, K., A. Haugen & C. C. Harris: An applied synchronous fluorescence spectrophotometric assay to study benzo(a)pyrene-diolepoxide-DNA adducts. Carcinogenesis 1985, 6, 1109-1116.
22. Vähäkangas, K. & O. Pelkonen: Host variations in carcinogen metabolism and DNA repair. In: Genetic epidemiology of cancer. Eds.: H. T. Lynch & T. Hirayama. CRC Press, Boca Raton, Florida, USA, 1989, pp. 35-54 (review).
23. Whitacre, C. M., H. Hashimoto, M.-L. Tsai, S. Chatterjee, S. J. Berger & N. A. Berger: Involvement of NAD-Poly(ADP-ribose) metabolism in p53 regulation and its consequences. Cancer Res. 1995, 55, 3697-3701.